ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2026
Chemotherapy-Activated GSK3β-DNMT1 Signaling Upregulates CD47 to Evade Macrophage Phagocytosis and Drive Temozolomide Resistance in Glioblastoma.
Jie Li et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.